未找到相关数据
A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC).
被引：88
作者：
Ang, K. K.
Zhang, Q. E.
Rosenthal, D. I.
Nguyen-Tan, P.
Sherman, E. J.
Weber, R. S.
Galvin, J. M.
Schwartz, D. L.
El-Naggar, A. K.
Gillison, M. L.
Jordan, R.
List, M. A.
Konski, A. A.
Thorstad, W. L.
Trotti, A.
Beitler, J. J.
Garden, A. S.
Spanos, W. J.
Yom, S. S.
Axelrod, R. S.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] RTOG Stat Ctr, Philadelphia, PA USA
[3] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[4] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[5] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[6] North Shore Long Isl Jewish Hlth Syst, New Hyde Pk, NY USA
[7] Ohio State Univ, Columbus, OH 43210 USA
[8] Univ Calif San Francisco, San Francisco, CA 94143 USA
[9] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA
[10] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[11] Washington Univ, Sch Med, St Louis, MO USA
[12] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[13] Emory Healthcare, Emory Clin, Atlanta, GA USA
[14] Univ Louisville, Sch Med, Louisville, KY 40292 USA
[15] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.5500
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5500
引用
收藏
页数：1
相关论文